Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: The Japan Clinical Oncology Group (JCOG) trial 0303

International Journal of Clinical Oncology

Volumn 17, Issue 2, 2012, Pages 105-111

  Sanuki, Naoko ^a   Ishikura, Satoshi ^b,c   Shinoda, Masayuki ^c   Ito, Yoshinori ^c   Hayakawa, Kazushige ^c   Ando, Nobutoshi ^d  

^a NATIONAL CANCER CENTER   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Radiotherapy Committee of Japan Clinical Oncology Group   (Japan)

^d Japan Esophageal Oncology Group of Japan Clinical Oncology Group (JEOG JCOG)   (Japan)

Author keywords

Clinical trial; Esophageal cancer; Quality assurance; Quality control; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; INCIDENCE; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; QUALITY CONTROL; RADIOTHERAPY DOSAGE;

EID: 84862882702     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0264-9     Document Type: Article

References (25)

1. Glicksman AS, Reinstein LE, McShan D et al (1981) Radiotherapy Quality Assurance Program in a cooperative group. Int J Radiat Oncol Biol Phys 7:1561-1568
2. Sanuki-Fujimoto N, Ishikura S, Hayakawa K et al (2009) Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. Radiat Oncol 4:16
3. Ohtsu A, Boku N, Muro K et al (1999) Definitive chemoradio-therapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915-2921
4. Gomi K, Oguchi M, Hirokawa Y et al (2003) Process and preliminary outcome of a patterns-of-care study of esophageal cancer in Japan: patients treated with surgery and radiotherapy. Int J Radiat Oncol Biol Phys 56:813-822
5. Kenjo M, Uno T, Murakami Y et al (2009) Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001. Int J Radiat Oncol Biol Phys 75:357-363
6. Kato H, Sato A, Fukuda H et al (2009) A phase II trial of che-moradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39:638-643
7. Wallner PE, Lustig RA, Pajak TF et al (1989) Impact of initial quality control review on study outcome in lung and head/neck cancer studies-review of the Radiation Therapy Oncology Group experience. Int J Radiat Oncol Biol Phys 17:893-900
8. Poortmans PM, Davis JB, Ataman F et al (2005) The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future. Eur J Surg Oncol 31:667-674
9. Hurkmans CW, Borger JH, Rutgers EJ et al (2003) Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run. Radiother Oncol 68:233-240
10. Dixon P, O'Sullivan B (2003) Radiotherapy quality assurance: time for everyone to take it seriously. Eur J Cancer 39:423-429
11. Haworth A, Kearvell R, Greer PB et al (2009) Assuring high quality treatment delivery in clinical trials-results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 ''RADAR'' set-up accuracy study. Radiother Oncol 90:299-306
12. Matzinger O, Poortmans P, Giraud JY et al (2009) Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review. Radiother Oncol 90:285-290
13. Poortmans P, Kouloulias V, van Tienhoven G et al (2006) Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol 182:576-582
14. Rischin D, Peters LJ, O'Sullivan B et al (2010) Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. J Clin Oncol 28:2989-2995
15. Peters LJ, O'Sullivan B, Giralt J et al (2010) Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol 28:2996-3001
16. White JE, Chen T, McCracken J et al (1982) The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: preliminary report of a Southwest Oncology Group study. Cancer 50:1084-1090
17. Abrams R, Winter K, Regine W (2006) RTOG 9704-Radio-therapy Quality Assurance (QA) Review and Survival. Int J Radiat Oncol Biol Phys 66:S22
18. Fabian CJ, Mansfield CM, Dahlberg S et al (1994) Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study. Ann Int Med 120:903-912
19. Perez CA, Stanley K, Grundy G et al (1982) Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer 50:1091-1099
20. Duhmke E, Franklin J, Pfreundschuh M et al (2001) Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone. J Clin Oncol 19:2905-2914
21. Poortmans PM, Venselaar JL, Struikmans H et al (2001) The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I-III breast cancer. Int J Radiat Oncol Biol Phys 49:1399-1408
22. Bentzen SM, Bernier J, Davis JB et al (2000) Clinical impact of dosimetryqualityassuranceprogrammesassessedbyradiobiological modellingofdatafromthe thermoluminescentdosimetry studyofthe European Organization for Research and Treatment of Cancer. Eur J Cancer 36:615-620
23. Ishikura S, Nihei K, Ohtsu A et al (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697-2702
24. Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425-433
25. Purdy JA (2008) Quality assurance issues in conducting multi-institutional advanced technology clinical trials. Int J Radiat Oncol Biol Phys 71:S66-S70